DNA vaccines against anthrax

Bibliography

• CHRISTOPHER GW, CIESLAK TJ, PAVLIN JA, EITZEN EM: Biological warfare. A historical perspective. JAMA (1997) 278(5):412–417.
   Google Scholar
• BAILLIE L, READ TD: Bacillus anthracis, a bug with attitude! Carr: Opin. Microbiol (2001) 4:78–81.
   Web of Science ®Google Scholar
• READ TD, PETERSON SN, TOURASSE H et al.: The genome sequence of Bacillus anthracis Ames and comparison to closely related bacteria. Nature (2003) 423:81–86.
   PubMed Web of Science ®Google Scholar
• ROSS JM: The pathogenesis of anthrax following the administration of spores by the respiratory route. J. Clin. Pathol (1957) 73: 485–494.
   Google Scholar
• GUIDI-RONTANI C, WEBER-LEVY M,LABRUYERE E, MOCK M: Germination of Bacillus anthracis spores within alveolar macrophages. Ma Microbiol (1999) 31:9–17.
   PubMed Web of Science ®Google Scholar
• DIXON TC, MESELSON M, GUILLEMIN J, HANNA PC: Anthrax. N Engl. J. Med. (1999) 341(11):815–826.
   PubMed Web of Science ®Google Scholar
• FRANZ DR, JAHRLING PB, FRIEDLANDER AM et al.: Clinical recognition and management of patients exposed to biological warfare agents. JAMA (1997) 278:399–411.
   PubMed Web of Science ®Google Scholar
• JERNIGAN JA, STEPHENS DS, ASHFORD DA et al.: Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg. Infect. Dis. (2001) 7(6):933–944.
   PubMed Web of Science ®Google Scholar
• MOCK M, FOUET A: Anthrax. Annu. Rev Microbiol (2001) 55:647–671.
   PubMed Web of Science ®Google Scholar
• •A review of anthrax and associated disease mechanisms.
   Google Scholar
• HOFFMASTER AR, RAVEL J,RASKO DA et al.: Identification of anthrax toxin genes in a Bacillus cereus associated with an illness resembling inhalation anthrax. Proc. Natl. Acad. Sci. USA (2004) 101:8449–8454.
   Google Scholar
• ••A significant paper describing thediscovery of both wild-type and modified anthrax toxin genes in a close relative of B. anthracis.
   Google Scholar
• SMITH H, KEPPIE J, STANLEY JL, HARRIS-SMITH PW: The chemical basis of the virulence of Bacillus anthracis. IV. Secondary shock as a major factor in thedeath of guinea pigs from anthrax. Br. J. Exp. Pathol (1955) 36:323–327.
   Google Scholar
• WELKOS S, FRIEDLANDER A, WEEKS S, LITTLE S, MENDELSON I: In-vitro characterization of the phagocytosis and fate of anthrax spores in macrophages and the effects of anti-PA antibody. Med. Microbiol (2002) 51(10):821–831.
   PubMed Web of Science ®Google Scholar
• TURNBULL PC: Current status of immunization against anthrax. Old vaccines may be here to stay for a while. Can: Opin. Infect. Dis. (2000) 13:113–120.
   PubMed Web of Science ®Google Scholar
• BAILLIE L: The development of new vaccines against Bacillus anthracis. Appl. Microbiol (2001) 91:609–613.
   Google Scholar
• KOCH R: Mitt. Kaiserliche Cesundheitsarnte (1881) 1:174–206.
   Google Scholar
• PASTEUR L: De l' attenuation des virus et de leur retour a' la virulence. CR Acad. Sci. Agric. Bulg. (1881) 92:429–435.
   Google Scholar
• TURNBULL PC: Anthrax vaccines: past, present and future. Vaccine (1991) 9:533–539.
   PubMed Web of Science ®Google Scholar
• WASSERMAN GM, GRABENSTEIN JD, PITTMAN PR et al: Analysis of adverse events after anthrax immunization in US Army medical personnel. ./. Occup. Environ. Med. (2003) 45(3):222–233.
   PubMed Web of Science ®Google Scholar
• JOELLENBECK L, ZWANZIGER LL, DURCH JS, STROM BL: The Anthrax Vaccine. B it Safe? Does it Work?Joellenbeck L, Zwanziger LL, Durch JS, Strom BL (Eds), National Academy Press, Washington DC, USA (2002).
   Google Scholar
• INGLESBY TV, O& TOOLE T, HENDERSON DA et al.: Anthrax as a biological weapon, 2002. Updated recommendations for management. JAMA (2002) 287(17):2236–2252.
   Google Scholar
• DONNELLY JJ, ULMER JB, LIU MA: DNA vaccines. Dev. Biol. Stand (1998) 95:43–53.
   PubMedGoogle Scholar
• TURNBULL PC, LEPPLA SH, BROSTER MG, QUINN CP, MELLING J: Antibodies to anthrax toxin in humans and guinea pigs and their relevance to protective immunity. Med. Microbiol Innnunol. (Berl) (1988) 177:293–303.
   PubMed Web of Science ®Google Scholar
• GU ML, LEPPLA SH, KLINMAN DM: Protection against anthrax toxin by vaccination with a DNA plasmid encoding anthrax protective antigen. Vaccine (1999) 17(4):340–344.
   PubMed Web of Science ®Google Scholar
• •First paper to describe the use of DNA vaccination against anthrax.
   Google Scholar
• WILLIAMSON ED, BEEDHAM RJ, BENNETT AM, MILLER J, BAILLIE LW: Presentation of the protective antigen of the mouse immune system: immune sequelae. Appl. Microbiol (1999) 87(2):315–317.
   Google Scholar
• PRICE BM, LINER AL, PARKS, LEPPLA SH, MATECZUN A, GALLOWAY DR: Protection against anthrax lethal toxin challenge by genetic immunization with a plasmid encoding the lethal factor protein. Infect. Inman. (2001) 69(7):4509–4515.
   PubMed Web of Science ®Google Scholar
• ••First paper to demonstrate protectionagainst anthrax by immunisation with LE
   Google Scholar
• TOWNSEND TJ, WILLIAMSON ED, FLICK-SMITH H, REDMOND C, BAILLIE LW: DNA vaccination as prophylaxic against anthrax. (unpublished).
   Google Scholar
• GALLOWAY D, LINER A, LEGUTKI J, MATECZUN A, BARNEWALL R, ESTEP J: Genetic immunization against anthrax. Vaccine (2004) 22:1604–1608.
   PubMed Web of Science ®Google Scholar
• ••First paper to demonstrate DNA-basedprotective immunisation against inhalational anthrax in a significant rabbit model challenge, and confirmation of the protective effect of immunisation targeting the LF antigen.
   Google Scholar
• HERMANSON G, WHITLOW V, PARKER S et al.: A cationic lipid formulated plasmid DNA vaccine confers sustained antibody-mediated protection against aerosolized anthrax spores. Proc. Natl. Acad. Sci. USA (2004) (In Press).
   Google Scholar
• ••Significant study demonstratingcomplete protection against inhalational anthrax in a rabbit model following formulated plasmid DNA-only immunisation, and confirmation of the protective effect of immunisation against the LF target antigen.
   Google Scholar
• TUCKER SN, LIN K, STEVENS S, SCOLLAY R, BENNETT MJ, OLSON DC: Systemic and mucosal antibody responses following retroductal gene transfer to the salivary gland. Ther. (2003) 8:392–399.
   Google Scholar
• RIEMENSCHNEIDERJ, GARRISON A, GEISBERT J et al.: Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus, Marburg virus and Venezuelan equine encephalitis virus. Vaccine (2003) 21:4071–4080.
   Google Scholar
• WILLIAMSON ED, BENNETT AM, PERKINS SD, BEEDHAM RJ, MILLERJ, BAILLIE LW: Co-immunization with a plasmid DNA cocktail primes mice againstanthrax and plague. Vaccine (2002) 20(23-24):2933–2941.
   PubMed Web of Science ®Google Scholar
• HOOPER JW, THOMPSON E, WILHELMSEN C et al.: Smallpox vaccine protects nonhuman primates against lethal monkeypox. Virol. (2004) 78(9):5533–5543.
   Google Scholar
• CHAPMAN G, LEGUTKI J,BRENNEMAN K et al.: Primate immune response to DNA vaccines encoding anthrax toxin components. ASM Biodefense Meeting. Baltimore, MD, USA (9–11 March 2004).
   Google Scholar
• STRATFORD R, DOUCE G,ZHANG-BARBER L, FAIRWEATHER N, ESKOLA J, DOUGAN G: Influence of codon usage on the immunogenicity of a DNA vaccine against tetanus. Vaccine (2001) 19:810–815.
   Web of Science ®Google Scholar
• OTTEN GR, DOE B, SCHAEFER M et al.: Relative potency of cellular and humoral immune responses induced by DNA vaccination. Litervirology (2000) 43:227–232.
   PubMed Web of Science ®Google Scholar
• JOHNSON PA, CONWAY MA, DALY J, NICOLSON C, ROBERTSON J,MILLS KH: Plasmid DNA encoding influenza virus hemagglutinin induces Thl cells and protection against respiratory infection despite its limited ability to generate antibody responses. J. Gen. Virol (2000) 81:1737–1745.
   PubMed Web of Science ®Google Scholar
• FISCHER L, MINKE J, DUFAY N, BAUDU P, AUDONNETJC: Rabies DNAvaccine in the horse: strategies to improve serological responses. Vaccine (2003) 21:4593–4596.
   PubMed Web of Science ®Google Scholar
• HARTIKKA J, BOZOUKOVA V, FERRARI M et al: Vaxfectin enhances the humoral immune response to plasmid DNA-encoded antigens. Vaccine (2001) 19:1911–1923.
   PubMed Web of Science ®Google Scholar
• TAN Y, HACKETT NR, BOYER JL, CRYSTAL RG: Protective immunity evoked against anthrax lethal toxin after a single intramuscular administration of an adenovirus-based vaccine encoding humanized protective antigen. Hum. Gene Thec (2003) 14(17):1673–1682.
   PubMed Web of Science ®Google Scholar
• LEE JS, HADJIPANAYIS AG,WELKOS SL: Venezuelan equine encephalitis virus-vectored vaccines protect mice against anthrax spore challenge. Infect. Immun. (2003) 71(3):1491–1496.
   PubMed Web of Science ®Google Scholar
• BOSIO CM, MOORE BD,WARFIELD KL et al: Ebola and Marburg virus-like particles activate human myeloid dendritic cells. Virology (2004) 326(2):280–287.
   PubMed Web of Science ®Google Scholar
• WOLFF JA, MALONE RW, WILLIAMS P et al: Direct gene transfer into mouse muscle in vivo. Science (1990) 247:1465–1468.
   PubMed Web of Science ®Google Scholar
• TANG DC, DE VIT M, JOHNSTON SA: Genetic immunization is a simple method for eliciting an immune response. Nature (1992) 356:152–154.
   PubMed Web of Science ®Google Scholar
• ROBINSON HL, HUNT LA,WEBSTER RG: Protection against lethal influenza challenge by immunization with a haemagglutinin-expressing plasmid DNA vaccine. Vaccine (1993) 11:957–960.
   PubMed Web of Science ®Google Scholar
• DAVIS HL, MICHEL ML,WHALEN RG: DNA-based immunization for hepatitis B induces continuous secretion of antigen and high levels of circulating antibody. Hum. Mol. Genet. (1993) 2:1847–1851.
   PubMed Web of Science ®Google Scholar
• WANG B, UGEN KE, SRIKANTAN V et al.: Gene inoculation generates immune responses against human immunodeficiency virus type I. Proc. Natl. Acad. Sci. USA (1993) 90:4156–4160.
   PubMed Web of Science ®Google Scholar
• http://www.anthrax.osd.mil/Anthrax Vaccine Immunization Program (AVIP). The Official DoD AVIP website.
   Google Scholar